Clinical decision-making is complex and multifactorial. We would like to provide you with a few tools that could support you in this process.
To furhter improve patient care, the several University Hospitals in Switzerland have developed and offer several diagnsotic tests to measure biologics trough-levels and anti-drug antibodies of Adalimumab, Certolizumab, Golimumab and Infliximab.
Test description
Adalimumab (french)
Certolizumab (french)
Goliumab (french)
Infliximab (french)
Vedolizumab (french)
Test procedure
(german)
Order Form USZ
(french)
Test Description Theradiag (french)
Information of how to proceed to get a test done:
(german) and (french)
The Swiss Society of Medical Officers and Insurance Physicians offers various requests for cost approvals and information letters to health insurers.
Go to Cost Approvals